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ABSTRACT 
Sudden death (SD) in children is rarer than in adults. In the pediatric population, SD accounts for less than one 
tenth of deaths from all causes. SD in infants is a separate entity commonly termed “sudden infant death syndrome 
(SIDS)”. Previous studies on SD in pediatric patients primarily focused on infants and showed that the incidence of 
SIDS was much lower in Asian countries than in Western ones. However, these differences diminished after edu-
cational campaigns such as the back to sleep act in the late 1980s to early 1990s. The incidence of SIDS from Wes-
tern reports has decreased from 2.69 to around 0.5-0.24 per 1,000 live births. Beyond infancy, the annual incid-
ence of SD ranges from 1.3 to 7.5 per 100,000. In 2009, two population-based studies, one from Taiwan and the 
other from the US, explored the epidemiological profile of SD in children. The child health care indexes of these 
two countries are similar, but the annual incidence of pediatric SD was 7.5 and 2.7 per 100,000 in the USA and Tai-
wan, respectively. The implications of ethic-related differences requires further confirmation. Around 40% of pe-
diatric SD could be from cardiac causes, either diagnosed or undiagnosed. Risk stratification for cardiac SD and pa-
tient selection for implantable cardioverter-defibrillator (ICD) therapy are recommended. However, the adoption of 
ICD as primary prevention for SD in children is still a challenging issue. Early detection of undiagnosed cardiac risk 
may be facilitated by cardiac screening either in newborns or the school-age population to better manage the risk of 
SD. However, the efficacy of such screening remains still controversial. (Korean Circ J 2010;40:253-257) 
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Sudden death (SD) is rarer in pediatric populations 
than adults. Less than 10% of pediatric deaths are sud-
den, and the age-specific risk for SD is around 1:16,000 
to 1:140,000.
1-6) SD in infants is a distinct clinical entity 
and commonly grouped as “Sudden infant death syn-
drome (SIDS)”. The rarity of the disease makes studies 
difficult, particularly in Asian populations, where the in-
cidence is even lower.   
 
Epidemiological Profile   
of Sudden Death 
 
In the West, the annual incidence of SD is 1.3-7.5 per 
100,000 in the pediatric population beyond infancy,
1-4)6) 
which are less than 10% of rates in adults.
7-9) The an-
nual incidence of SD in the general population is 1 in 
1,000, a conservative estimate that does not account for 
unwitnessed events. Around 4% of SD in adults is un-
explained, with no discernible abnormalities on histo-
pathology and a negative toxicology screen. Termed “sud-
den arrhythmic death syndrome”, some may be due to 
inherited cardiac arrhythmia syndrome from channe-
lopathy.
10) Similar SD may account for most SD in the 
pediatric population without structural cardiac diseases. 
In an early study by Driscoll and Edwards,
3) there 
were 12 SDs in the population aged 1-22 years from 
1950 to 1982, giving an annual incidence of 1.3 per 
100,000. Wren et al.
1) reported an annual incidence of 
SD of 3.3 per 100,000 in the population aged 1-20 
years in the Northern Health Region of England from 
1985 to1994. In the study by Neuspiel and Kuller
4) the 
annual incidence of SD was 4.6 per 100,000 in the po-
pulation aged 1-20 years. In a recent report from Ore-
gon (population 660,486), the pediatric SD constituted 
only 2.8% of all SD of the population, and the annual 
incidence of SD per 100,000 children (0-17 years) was 
7.5 {95% confidence interval (CI) 5.1-10.5}, compared 
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with 60/100,000 for all ages.
6) In Asian populations, such 
data are still limited. Our study, based on the Taiwan Na-
tional Health Insurance Database 2000-2006, revealed 
that in Taiwan (the average pediatric population 0-18 
years was 5.44 million), the annual SD rate was 2.7 (95% 
CI: 2.6-2.9) per 100,000 in the population aged 1-18 
years.
5) I n  a n o t h e r  s t u d y  f r o m  J a p a n ,  i n  s c h o o l  a g e  
children, the annual incidence of SD was estimated as 
6.4 per 100,000.
11) 
The incidence of SIDS is lower in Asian populations 
than in the West,
12-21) but rates are declining in most 
Western countries.
12-15)22) Educational campaigns in the 
late 1980s to early 1990s, such as the “back to sleep” act, 
have decreased the incidence of SIDS from 2.69 to ar-
ound 0.5-0.24 per 1,000 live births.
12-15)22) In Asian coun-
tries, most parents adopt a traditional “back to sleep” pos-
ture for infants, which could lead to low SIDS rates. 
An international comparison of child health care in-
dexes (newborn, infant, under-5, and 1-18 years popul-
ation mortality), SIDS incidence, and SD in the pedia-
tric population beyond infancy in 2005 were similar in 
most countries (Table 1). However, the infant, newborn, 
and under-five mortalities are relatively low for Japan, 
Norway, and Sweden, as was SIDS. SIDS rates best cor-
related to infant mortality (p=0.030), borderline to the 
newborn mortality (p=0.079), and not to postneonatal 
mortality (p= 0.119) or under-five mortality (p=0.238). 
Limited data on SD incidence beyond infancy made 
an association between the incidence of SD and child 
health care indexes difficult to ascertain, with rates rang-
ing from 1.3 to 7.5 per 100,000 person-years. Two studies 
in 2009 showed an annual SD incidence in non-infant 
pediatrics of 7.5 (2002-5) and 2.7 (2000-6), with all-cause 
rates of 32.7 (2004) and 33.2 (2000-6), in the United 
States and Taiwan, respectively.
5)6) The proportion of SD 
to all-cause mortality was 22.9% for USA and 8.1% for 
Taiwan.
5)6) Further work is needed to confirm these dif-
ferences in the rates of SD to overall mortality. 
We previously showed that the age-specific SD rate pa-
ralleled the all-cause mortality rate, with a nadir around 
early puberty (8-13 years).
5) The proportionate SD mor-
tality ratio ranged from 1.8% to 12.0% (8.9±2.2%), with 
the lowest rate in 11 to 12-year-olds. The proportionate 
SD mortality ratio in infants (6.2%) was not significantly 
higher than other age groups.   
 
Sudden Death Related 
to Cardiac Diseases 
 
SD may occur in cardiac diseases such as 1) diagnosed 
cardiac diseases with risk of SD, such as repaired tetralogy 
of Fallot, transposition of the great arteries after atrial 
switch operation, Eisenmenger complex, Marfan syn-
drome, etc, 2) undiagnosed disease, mainly hypertrophic 
cardiomyopathy, primary cardiac arrhythmias {Wolff-Par-
kinson-White (WPW) syndrome, long QT syndrome 
(LQTS), catecholinergic polymorphic ventricular tachy-
cardia, Brugada syndrome, short QT syndrome and ar-
rhythmogenic right ventricular dysplasia}, and 3) acquir-
ed cardiac illness, such as myocarditis, commotio cordis, 
cocaine intoxication, etc.
23-27) Around 40% of SD may be 
due to underlying cardiac diseases.
27) 
 
Congenital Heart Disease  
and Sudden Death 
 
Patients with repaired congenital heart disease (CHD) 
have an SD risk during late follow-up. The risk of late SD 
increased incrementally 20 years after surgery for tetra-
logy of Fallot, aortic stenosis, and coarctation. In repair-
ed CHD patients, the risk of nonsudden cardiac death 
was 1.6 per 1,000 patient-years, the risk of SD was 0.9 
per 1,000 patient-years.
28) The risk of SD was higher than 
non-sudden cardiac death for aortic stenosis and tetra-
Table 1. International comparison of the mortality relevant to child health care indexes and the incidence of sudden death in infants (SIDS)
and sudden death in 2005 and in pediatric population beyond infancy 
  Infant mortality*  NB mortality* PNM* Under-5 mortality* SIDS*  Sudden death,
†  >1 years 
Australia 
Canada 
Germany 
Ireland 
Japan 
Korea 
Norway 
Sweden 
Taiwan 
United Kingdom 
USA 
5 
5 
4 
4 
3 
5 
3 
3 
5 
5 
7 
3.7 
3.7 
2.6 
2.9 
1.6 
4
‡ 
2.0 
2.0 
2.9 
3.4 
4.7 
1.3 
1.3 
1.4 
1.1 
1.4 
1.0 
1.0 
1.0 
2.4 
1.6 
2.3 
6 
6 
5 
5 
6 
6 
4 
4 
8 
6 
8 
0.32 
0.24 
0.43 
0.38 
0.16 
0.56
19) 
0.30 
0.23 
0.35 
0.30 
0.54 
 
 
 
 
6.4 (1989, school age)
11) 
 
 
 
2.6 (2005)
5) 
3.3 (1985-1994)
1) 
4.6 (1972-1982)
4) (1-21 years)
1.3 (1950-1982)
3) (1-22 years)
7.5 (2002-2005)
6) (1-17 years)
Data of infant and under-five mortality are obtained from Unicef website (http://www.unicef.org). *Per 1,000 live births, †Per 100,000 person-
years, ‡2004. NB mortality: newborn mortality, PNM: postneonatal mortality    
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logy of Fallot. Patients should undergo risk stratification 
for SD and consider elective implantable cardioverter-
defibrillator (ICD) implantation after repaired tetralogy 
of Fallot.
29-32) The role of electrophysiology studies to id-
entify high risk patients has also been documented.
30) 
Non-invasive screening parameters, such as QRS durat-
ion, QTc interval, and QTc and JTc dispersion from a 
12-lead electrocardiogram are useful predictors of SD.
31) 
Among adults with CHD, including unrepaired CHD, 
the incidence of SD is 5.3 per 1,000 patient-years.
33) The 
most common disease entities in SD were Eisenmenger 
complex, tetralogy of Fallot, and transposition of the 
great arteries. SD accounts for the highest proportion 
of death in coarctation of the aorta, Ebstein’s anomaly, 
and transposition of great arteries. Most SD was found 
in the tetralogy of Fallot because of the patient popul-
ation is relatively large. In a Japanese cohort of 253 pa-
tients from 15 institutions, 23 (9%) patients died at 29 
(18-54) years of age and SD occurred in 6 (2.3%) patients, 
mainly in those with pulmonary vascular diseases.
34) In 
another long-term follow up study of 167 patients who 
received total repair between 1965 and 1975 at a median 
age of 6 years, SD occurred in 7 (4%) patients.
35) In As-
ians, we have demonstrated that the incidence of tetra-
logy of Fallot is higher than in Western countries.
36) With 
advances in cardiac interventions, most of these patients 
may survive into adulthood. Long-term management of 
these patients, including the risk stratification and pre-
vention for SD, will be a very important issue.   
 
Sudden Death in Children  
With Cardiomyopathy  
 
Hypertrophic cardiomyopathy is the most important 
cause of SD in young athletes. In a study of 99 children 
with hypertrophic cardiomyopathy, the reported annual 
incidence of SD and cardiac arrest was 2.7% between 
the age of 8 and 18 years.
37) The risk factors included a 
family history of SD from hypertrophic cardiomyopathy, 
recurrent syncope, non-sustained ventricular tachycar-
dia on an ambulatory electrocardiography (ECG), and 
extreme left ventricular hypertrophy.
37)38) In a previous 
study from Finland, the risk of SD from previously un-
suspected hypertrophic cardiomyopathy is low, with an 
age-specific risk in apparently normal children or ado-
lescents of less than 1 in 1,000,000 per year.
39)  
 
Sudden Death in Children  
With Primary Cardiac Arrhythmias  
 
Most patients with primary cardiac arrhythmias have 
undiagnosed cardiac diseases that account for unexpl-
ained SD. Some primary cardiac arrhythmias may be de-
tected early by cardiac screening.
40-44) For example; WPW 
syndrome and long-QT syndrome can be identified in 
schools during an electrocardiogram screening, but risk 
stratification for asymptomatic children with ECG abnor-
malities remains challenging.
40) 
SD in patients with WPW syndrome occurs after the 
development of atrial fibrillation that conducts though 
an accessory pathway with a very short refractory period 
and degenerates into ventricular fibrillation.
45) SD in 
WPW patients ranges from 0.09% to 0.6% per patient 
year of follow-up.
46)47) SD mainly occurs in adolescents 
and adults and rarely in childhood. Therefore, radio-
frequency transcatheter ablation is recommended for 
symptomatic patients at the appropriate ages,
47) and ob-
servation for asymptomatic patients.   
The incidence of LQTS is 1:20,000 to 1:5,000.
48)49) 
Using ECG-guided identification of disease-causing mu-
tations, the prevalence of LQTS in apparently healthy 
live births was around 1:2,534 (95% CI, 1:1,583 to 1: 
4,350).
50) Most of the mutations were in KCNQ1 (LQT1), 
KCNH2 (LQT2), and SCN5A (LQT3) genes. The risk 
of SD in LQTS is associated with the gender, extent of 
QT prolongation, and underlying channelopathy. The 
latest report from the International LQTS Registry sh-
owed that LQTS boys experience a significantly higher 
rate of fatal or near-fatal cardiac events than girls dur-
ing childhood.
50) A QTc duration >500 ms and a history 
of prior syncope identify risk in boys, whereas a history 
of prior syncope is the only significant risk factor among 
girls. Beta-blocker therapy may decrease the risk of life-
threatening cardiac events during childhood. Therefore, 
ICD implantation is only recommended for patients 
with recurrent syncope despite drug therapy, sustained 
ventricular arrhythmias, or averted SD.
51) A strong fa-
mily history of SD or compliance and intolerance issues 
may also prompt ICD implantation.
51) 
 
Strategies to Detect and Treat Children 
at Risk of Sudden Death 
 
SD from life-threatening arrhythmias can potentially 
be prevented by ICD, on either a primary or secondary 
prevention basis.
51)52) While ICD implantation is re-
commended for those with prior averted SD, ventricular 
arrhythmias, and syncope, ICD as primary SD preven-
tion in high-risk children remains controversial. Risk st-
ratification of cardiac disease and SD risk is often made 
according to electrophysiological data and hemodynamic 
abnormalities, but no parameter has satisfactory posi-
tive and negative predictive values for predicting SD. Th-
erefore, ICD therapy is limited to secondary prevention 
of ventricular arrhythmias, syncope, and after SD.   
Undiagnosed cardiac disease may be detected by screen-
ing with a detailed history, physical examination, and el-
ectrocardiogram. Disease-specific management and edu-
cation may reduce SD probability, but the timing for in-
vasive management, including electrophysiological stu- 
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dies, disease specific interventions, and ICD remains ch-
allenging. In children, the problem of inappropriate shock 
at follow-up adds further controversy to ICD implantation. 
In conclusion, SD in children is rarer than adults and 
accounts for less than one tenth of all deaths in child-
ren. Ethnic differences in SIDS incidence have decre-
ased after educational campaigns in the West. Two re-
cent studies still indicate ethnic differences in SD in-
cidence beyond infancy. Risk stratification for cardiac 
disease and early detection of undiagnosed disease may 
identify children with a high risk of SD. Subsequent dise-
ase-specific management may reduce the risk of SD. The 
role of ICD, particularly in the primary prevention of SD, 
remains a challenging issue in the pediatric population.   
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